Double stem cell transplant shows promise for rare blood disorder

NCT ID NCT07499284

First seen Apr 20, 2026 · Last updated May 20, 2026 · Updated 4 times

Summary

This study is for people with aplastic anemia, a condition where the bone marrow stops making enough blood cells. Researchers are testing if adding umbilical cord blood to a half-matched stem cell transplant from a family member can help the body accept the new cells faster and with fewer side effects. The goal is to improve survival and reduce complications like graft-versus-host disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APLASTIC ANAEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hematology Department, The First Affiliated Hospital of Soochow University

    RECRUITING

    Suzhou, Jiangsu, China 215006, China

  • Suzhou Hongci Hematology Hospital

    RECRUITING

    Suzhou, Jiangsu, China 215006, China

  • The Affiliated Hospital of Xuzhou Medical University

    RECRUITING

    Xuzhou, Jiangsu, China 221006, China

  • The First Affiliated Hospital of Zhejiang Chinese Medical University

    RECRUITING

    Hangzhou, Zhejiang, China 310006, China

Conditions

Explore the condition pages connected to this study.